Clinical Trials · NCT01618513
Treatment of Acromegaly With Somatostatin Analogs: GH vs. IGF-I as Primary Biochemical Target
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- University of Aarhus
- Enrollment
- 84
- Start date
- Jun 2012
- Locations
- 1 site, Denmark
- Primary endpoint
- Change in Quality of Life